NanoViricides Reports Juvenile-Mouse Safety Data for NV-387
The company said oral NV-387 gummies showed no observed adverse effect at up to 3,690 mg/kg/day in juvenile mice. It said the data support plans to add pediatric cohorts to future Phase III Ebola and mpox trials and pursue measles trials.